In this interview, a US KOL shares their treatment paradigms for major depressive disorder and postpartum depression, as well as their thoughts on late-stage pipeline drugs. They also discuss which subpopulations in depression might be the most successful to target with a New Drug Application. 

This interview was conducted on Oct. 2, 2024. 

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal. 

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.